Alzheimer’s drug from Eisai, Biogen shows promise in large trial
Eisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug…
Read MoreEisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug…
Read MoreTwitter Inc. and Elon Musk continue to jockey for preliminary legal advantage ahead of a…
Read MoreHalfway through a six-month trial in the U.K., businesses allowing employees to work four days…
Read MoreData from a trial seeking to determine whether multiple injections of a tuberculosis vaccine developed…
Read MoreAstraZeneca PLC said Monday that its Enhertu drug significantly delayed metastatic breast cancer progression in…
Read MoreThe daily average of new U.S. cases may have started to decline based on official…
Read MoreThe daily average of new U.S. cases may have started to decline based on official…
Read MoreKHIMKI, Russia (AP) — U.S. basketball star Brittney Griner was convicted Thursday in Russia of…
Read MoreTwitter Inc. responded Monday to Elon Musk’s motion opposing the company’s request to expedite a…
Read MoreElon Musk filed a motion Friday opposing Twitter Inc.’s request to expedite a trial over…
Read More